Table 2 Treatment substances administered to horses of the three treatment groups on days 1, 22 and 78
From: Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma
Vaccine component | Dose per injection | ||
|---|---|---|---|
| Â | Group eqIL12/18 | Group hgp100 | Group htyr |
MIDGE-Th1 eqIL12 | 200 μg | 200 μg | 200 μg |
MIDGE-Th1 eqILRAPIL18 | 200 μg | 200 μg | 200 μg |
MIDGE-Th1 hgp100 | - | 500 μg | - |
MIDGE-Th1 htyr | - | - | 500 μg |
SAINT 18 | 0.35 μmol | 0.675 μmol | 0.675 μmol |